High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302)

By sjmartinez • April 29, 2025

Riddler SA, Moodie Z, Clark J, Yen C, Allen M, Furch BD, Lu H, Grant S, Mondal K, Anderson M, Maenza J, Lemos MP, Woodward Davis AS, Walsh SR, Sobieszczyk ME, Frank I, Goepfert P, Stephenson KE, Baden LR, Tieu HV, Keefer MC, McElrath MJ, Kublin JG, Corey L. High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302). Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-24-02701. Epub ahead of print. PMID: 40294415.

Tags: Infectious Diseases, Publications

Hypertension in a randomized trial of dolutegravir- versus efavirenz-based antiretroviral therapy in pregnant and postpartum women with HIV

Hoffman R, Brummel S, Pinilla M, Malonga G, Chinula L, Stranix-Chibanda L, Machado ES, Naik S, Rathore MH, Pilotto J, Masheto G, Stringer JSA, Shapiro[...]

HIVST in the presence of a partner among fishermen in Western Kenya: A qualitative stud

Abade P, Olugo P, Gutin SA, Nishimura H, Lewis-Kulzer J, Thorp M, Ayieko B, Oluoch L, Angawa D, Camlin CS, Kwena ZA. HIVST in the[...]

Inhibition of Candida albicans yeast-to-hypha transition and virulence by cyclic dipeptides derived from probiotic Aeromonas veronii V03

Sekar J, Parasuraman G, Shanmugam A, Dharumadurai D, Dileep Kumar BS, Natesan S. Inhibition of Candida albicans yeast-to-hypha transition and virulence by cyclic dipeptides derived[...]